OA09555A - Inhibition of HIV using synergistic combinations of nucleoside derivatives - Google Patents

Inhibition of HIV using synergistic combinations of nucleoside derivatives

Info

Publication number
OA09555A
OA09555A OA60072A OA60072A OA09555A OA 09555 A OA09555 A OA 09555A OA 60072 A OA60072 A OA 60072A OA 60072 A OA60072 A OA 60072A OA 09555 A OA09555 A OA 09555A
Authority
OA
OAPI
Prior art keywords
hiv
inhibition
nucleoside derivatives
synergistic combinations
synergistic
Prior art date
Application number
OA60072A
Other languages
English (en)
Inventor
Vera Brankovan
Richard J White
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of OA09555A publication Critical patent/OA09555A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA60072A 1989-03-17 1991-09-17 Inhibition of HIV using synergistic combinations of nucleoside derivatives OA09555A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US40190889A 1989-09-01 1989-09-01

Publications (1)

Publication Number Publication Date
OA09555A true OA09555A (en) 1993-01-31

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60072A OA09555A (en) 1989-03-17 1991-09-17 Inhibition of HIV using synergistic combinations of nucleoside derivatives

Country Status (19)

Country Link
EP (1) EP0464137A4 (fr)
JP (1) JPH04504850A (fr)
KR (1) KR920700653A (fr)
CN (1) CN1045791A (fr)
AU (1) AU5351490A (fr)
CA (1) CA2050473A1 (fr)
DD (1) DD301787A9 (fr)
FI (1) FI914367A0 (fr)
GR (1) GR1000618B (fr)
HU (1) HU208254B (fr)
IL (1) IL93783A0 (fr)
NO (1) NO913659L (fr)
NZ (1) NZ232912A (fr)
OA (1) OA09555A (fr)
PL (1) PL284343A1 (fr)
PT (1) PT93449A (fr)
WO (1) WO1990011081A1 (fr)
YU (1) YU53790A (fr)
ZW (1) ZW3290A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
CA2335617C (fr) * 1998-06-24 2009-12-15 Emory University 3'-azido-2',3'-dideoxyuridine (cs-87) utilise en combinaison avec d'autres medicaments anti-vih pour la fabrication d'un medicament destine a traiter le vih
AU2002255707A1 (en) 2001-03-15 2002-10-03 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (fr) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition du caractere infectieux et de l'effet cytopathique du htlv-iii/lav in vitro par la 2',3'-dideoxyinosine, 2',3'-dideoxyguanosine, ou 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
HUT57988A (en) 1992-01-28
PL284343A1 (en) 1991-06-03
GR1000618B (el) 1992-08-31
NO913659D0 (no) 1991-09-17
EP0464137A1 (fr) 1992-01-08
ZW3290A1 (en) 1990-11-07
JPH04504850A (ja) 1992-08-27
CN1045791A (zh) 1990-10-03
CA2050473A1 (fr) 1990-09-18
GR900100189A (en) 1990-07-31
YU53790A (sh) 1993-05-28
NO913659L (no) 1991-10-18
FI914367A0 (fi) 1991-09-17
HU208254B (en) 1993-09-28
PT93449A (pt) 1990-11-07
DD301787A9 (de) 1994-01-13
NZ232912A (en) 1992-06-25
KR920700653A (ko) 1992-08-10
AU5351490A (en) 1990-10-22
EP0464137A4 (en) 1992-01-15
IL93783A0 (en) 1990-12-23
WO1990011081A1 (fr) 1990-10-04
HU902898D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
GB2212498B (en) Adenosine derivatives
NZ225542A (en) Avermectin derivatives and parasiticidal compositions
NZ222527A (en) N 9 -cyclopentyl-substituted adenosine derivatives and intermediate compound and pharmaceutical compositions
AU3978689A (en) Nucleoside derivatives
GR3003177T3 (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0432600A3 (en) Derivatives of 2-iminopyridine
NZ223272A (en) Avermectin derivatives and parasiticidal compositions
NZ223771A (en) Avermectin derivatives and parasiticidal compositions
HU9300032D0 (en) Phenyl-acetamide derivatives of hiv inhibiting effect
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
IL91415A0 (en) Pharmaceutical compositions containing adenosine derivatives
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
GB2333292B (en) Derivatives of hexaazoisowurtzitane
OA09697A (en) Nucleoside derivatives
NZ219250A (en) Purine derivatives and pharmaceutical compositions
ZW3290A1 (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
EP0431799A3 (en) Use of nucleoside derivatives as cytotoxic agents
YU53490A (en) Derivatives of tetrahydronaphtaline
ZM990A1 (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
EP0450102A4 (en) Nucleoside derivative
IE900934L (en) Inhibition of hiv using synergistic combinations of¹nucleosides
IL101084A0 (en) Preparation of nucleoside derivatives
GB8925037D0 (en) Nucleoside derivatives
GB8925039D0 (en) Nucleoside derivatives
CS56288A1 (en) Derivatives of adenine